Clinical Trial Update: An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating an efficacy and safety study of basimglurant (NOE-101) for trigeminal neuralgia is ongoing in Phase 2/Phase 3 and currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• Basimglurant (NOE-101) (basimglurant)

Snippet

Sponsor: Noema Pharma AG | Conditions: Trigeminal Neuralgia | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING